Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?

Evangelos Oikonomou, Gerasimos Siasos, Dimitris Tousoulis

Journal: International journal of cardiology 2016;202():586-8

PMID: 26447667

Full Text on Elsevier Science View on PubMed

Abstract

Address: 1st Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece. Electronic address: [email protected].; 1st Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; Department of Biological Chemistry, University of Athens Medical School, Athens, Greece.; 1st Department of Cardiology, 'Hippokration' Hospital, University of Athens Medical School, Athens, Greece.

DOI: 10.1016/j.ijcard.2015.09.059

Link outs

Free resources

Medical:

https://medlineplus.gov/atherosclerosis.html

Other Literature Sources:

https://scite.ai/reports/26447667

Subscription / membership required

Full Text Sources:

MeSH Terms: Amino Acids, Apolipoproteins B, Atherosclerosis, Biomarkers, Humans, Hyperlipidemias, Lipoprotein(a), Peptide Fragments, Randomized Controlled Trials as Topic, Receptors, Lipoprotein, Risk Factors